Anacor Pharmaceuticals Registers IPO Plan With SEC

Anacor Pharmaceuticals Inc. filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common shares. The number of shares to be offered and the price range for the offering have not yet been determined. Prior to the IPO, Rho Ventures holds a 25.5 percent stake, Venrock Associates 16.1 percent, Care Capital LLC 12.4 percent and Aberdare Ventures 11.5 percent.

North AmericaUSBriefs